Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 5,385 | 5,931 | 6,369 | 8,844 | 7,098 |
| Operating Income | -5,385 | -5,931 | -6,369 | -8,844 | -7,098 |
| Interest Expense | 84 | 98 | 118 | 124 | 124 |
| Other Income | 31 | 15 | 23 | 19 | 6 |
| Pre-tax Income | -5,438 | -6,014 | -6,464 | -8,949 | -7,216 |
| Net Income Continuous | -5,438 | -6,014 | -6,464 | -8,949 | -7,216 |
| Net Income | $-5,438 | $-6,014 | $-6,464 | $-8,949 | $-7,216 |
| EPS Basic Total Ops | -1.04 | -1.24 | -1.32 | -1.84 | -1.48 |
| EPS Basic Continuous Ops | -1.06 | -1.23 | -1.33 | -1.83 | -1.48 |
| EPS Diluted Total Ops | -1.04 | -1.24 | -1.32 | -1.84 | -1.48 |
| EPS Diluted Continuous Ops | -1.06 | -1.23 | -1.33 | -1.83 | -1.48 |
| EBITDA(a) | $-5,374 | $-5,922 | $-6,361 | $-8,835 | $-7,094 |